Cargando…

Epithelial ovarian cancer risk: A review of the current genetic landscape

Ovarian cancer is the fourth most common cause of cancer‐related death in women in the developed world, and one of the most heritable cancers. One of the most significant risk factors for epithelial ovarian cancer (EOC) is a family history of breast and/or ovarian cancer. Combined risk factors can b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Flaum, Nicola, Crosbie, Emma J., Edmondson, Richard J., Smith, Miriam J., Evans, Dafydd G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2019
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017781/ https://www.ncbi.nlm.nih.gov/pubmed/31099061 http://dx.doi.org/10.1111/cge.13566

Ejemplares similares

Is Reflex Germline BRCA1/2 Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?
por: Morgan, Robert D., et al.
Publicado: (2023)

MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1
por: Flaum, Nicola, et al.
Publicado: (2023)

Specialist oncological surgery for removal of the ovaries and fallopian tubes in BRCA1 and BRCA2 pathogenic variant carriers may reduce primary peritoneal cancer risk to very low levels
por: Crosbie, Emma J., et al.
Publicado: (2020)

Targeting lung cancer screening to individuals at greatest risk: the role of genetic factors
por: Lebrett, Mikey B, et al.
Publicado: (2021)

The prevalence of mismatch repair deficiency in ovarian cancer: A systematic review and meta‐analysis
por: Atwal, Amit, et al.
Publicado: (2022)

Association between genetic polymorphisms and endometrial cancer risk: a systematic review
por: Bafligil, Cemsel, et al.
Publicado: (2020)

Detection of MCM5 as a novel non-invasive aid for the diagnosis of endometrial and ovarian tumours
por: Stockley, J., et al.
Publicado: (2020)

Cervical screening: the evolving landscape
por: Davies-Oliveira, Jennifer C, et al.
Publicado: (2022)

BRCA1 and BRCA2 pathogenic variant carriers and endometrial cancer risk: A cohort study
por: Kitson, Sarah J., et al.
Publicado: (2020)

Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison study
por: Hawarden, Amy, et al.
Publicado: (2021)

Correction to: Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison study
por: Hawarden, Amy, et al.
Publicado: (2021)

Rare Germline Genetic Variants and the Risks of Epithelial Ovarian Cancer
por: Pavanello, Marina, et al.
Publicado: (2020)

The Molecular Landscape Influencing Prognoses of Epithelial Ovarian Cancer
por: Liu, Chao-Lien, et al.
Publicado: (2021)

Immune checkpoint inhibitors efficacy across solid cancers and the utility of PD-L1 as a biomarker of response: a systematic review and meta-analysis
por: Fitzsimmons, Timothy S., et al.
Publicado: (2023)

Landscape of Immune Microenvironment in Epithelial Ovarian Cancer and Establishing Risk Model by Machine Learning
por: Liu, Shi-yi, et al.
Publicado: (2021)

The Landscape and Therapeutic Implications of Molecular Profiles in Epithelial Ovarian Cancer
por: Dion, Ludivine, et al.
Publicado: (2020)

BRCA and lynch syndrome-associated ovarian cancers behave differently
por: Ryan, Neil A.J., et al.
Publicado: (2017)

Urinary biomarkers for the detection of ovarian cancer: a systematic review
por: Owens, Gemma L, et al.
Publicado: (2022)

The unrecognized burden of cardiovascular risk factors in women newly diagnosed with endometrial cancer: A prospective case control study
por: Kitson, Sarah J., et al.
Publicado: (2018)

The genetic landscape of high-risk neuroblastoma
por: Pugh, Trevor J., et al.
Publicado: (2013)

The Current Landscape of Genetic Testing in Cardiovascular Malformations: Opportunities and Challenges
por: Landis, Benjamin J., et al.
Publicado: (2016)

Combination treatment with rucaparib (Rubraca) and MDM2 inhibitors, Nutlin-3 and RG7388, has synergistic and dose reduction potential in ovarian cancer
por: Zanjirband, Maryam, et al.
Publicado: (2017)

Distinct Immunological Landscapes Characterize Inherited and Sporadic Mismatch Repair Deficient Endometrial Cancer
por: Ramchander, Neal C., et al.
Publicado: (2020)

Inherited Cancer Genetic Epidemiology to Improve Precision Medicine
por: Møller, Pål, et al.
Publicado: (2022)

Current and Emerging Prognostic Biomarkers in Endometrial Cancer
por: Njoku, Kelechi, et al.
Publicado: (2022)

The current trend of exosome in epithelial ovarian cancer studies: A bibliometric review
por: Baghban, Neda, et al.
Publicado: (2023)

Epigenetic therapy for the treatment of epithelial ovarian cancer: A clinical review
por: Smith, Haller J., et al.
Publicado: (2017)

PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
por: Morgan, Robert D., et al.
Publicado: (2018)

Identifying Ovarian Cancer in Symptomatic Women: A Systematic Review of Clinical Tools
por: Funston, Garth, et al.
Publicado: (2020)

Genomic landscape and immune-related gene expression profiling of epithelial ovarian cancer after neoadjuvant chemotherapy
por: Lodewijk, I., et al.
Publicado: (2022)

Pathological features and clinical behavior of Lynch syndrome-associated ovarian cancer
por: Ryan, N.A.J., et al.
Publicado: (2017)

Regulation of immune responses by the airway epithelial cell landscape
por: Hewitt, Richard J., et al.
Publicado: (2021)

Detecting ovarian cancer in primary care: can we do better?
por: Funston, Garth, et al.
Publicado: (2022)

Preferences of women with epithelial ovarian cancer for aspects of genetic testing
por: Davidson, Brittany A., et al.
Publicado: (2019)

Comprehensive epithelial tubo-ovarian cancer risk prediction model incorporating genetic and epidemiological risk factors
por: Lee, Andrew, et al.
Publicado: (2022)

The tumor multi-omic landscape of endometrial cancers developed on a germline genetic background of adiposity
por: Richenberg, George, et al.
Publicado: (2023)

Therapeutics in paediatric genetic diseases: current and future landscape
por: Koh, Ai Ling, et al.
Publicado: (2023)

The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer
por: Xu, Yufei, et al.
Publicado: (2022)

Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC)
por: Jim, Heather S.L., et al.
Publicado: (2015)

Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
por: Chornokur, Ganna, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6es28d7j7943je0nmi0jlnp7sa